Akathisia in Post Operative Outpatients Surgery | NCT01942343 | Trialant

Akathisia in Post Operative Outpatients Surgery | NCT01942343 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Arm 1 : Droperidol 1,25 mg	Active Comparator		Drug: Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration
Arm 2 : Droperidol 0,625 mg	Active Comparator		Drug: Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration
Arm 3 : Odansetron 4 mg	Active Comparator		Drug: Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration	Drug		Arm 1 : Droperidol 1,25 mg Arm 2 : Droperidol 0,625 mg Arm 3 : Odansetron 4 mg

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Incidence of akathisia	The main objective of this study was to evaluate the incidence of akathisia with the waning of prophylactic treatment of PONV with droperidol used two different doses versus control group (ondansetron), ambulatory surgery	1 day

Contacts/Locations Module

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
29746373	Result	Charton A, Greib N, Ruimy A, Faitot V, Noudem Y, Joshi GP, Meyer N, Diemunsch P. Incidence of akathisia after postoperative nausea and vomiting prophylaxis with droperidol and ondansetron in outpatient surgery: A multicentre controlled randomised trial. Eur J Anaesthesiol. 2018 Dec;35(12):966-971. doi: 10.1097/EJA.0000000000000821.

Condition Browse Module